潜在不适当用药与早期老年期衰弱的关联:GAZEL队列纵向研究
该研究嵌套于GAZEL队列,纳入2012年58至73岁社区居住者12405人并随访3年,用Strawbridge问卷每年评估衰弱,依据报销数据判定多重用药与潜在不适当用药(PIM)。结果显示多重用药与非甾体抗炎药不适当使用与衰弱发生显著相关,至少1种PIM与衰弱风险呈弱关联。
要点
- 多重用药5至9种及10种以上均与衰弱发生显著相关。
- 非甾体抗炎药潜在不适当使用与衰弱发生相关(aHR 1.33)。
- 至少1种PIM与衰弱风险仅呈弱关联(aHR 1.15)。
核心结论
- 不适当处方与老年人衰弱发生存在关联,尤其多重用药值得关注。
研究设计与样本
- 前瞻性观察研究,嵌套于GAZEL队列,纳入2012年58至73岁社区居住者12405人,随访3年。
主要发现
- 衰弱患病率从2012年14%升至2014年17%,PIM频率从2012年29%降至2014年23%。
- 多重用药5至9种与衰弱发生相关(aHR 1.31,95%CI 1.14-1.50)。
- 多重用药10种及以上与衰弱发生相关(aHR 1.57,95%CI 1.28-1.92)。
- 非甾体抗炎药潜在不适当使用与衰弱发生相关(aHR 1.33,95%CI 1.04-1.71)。
- 至少1种PIM与衰弱风险呈弱关联(aHR 1.15,95%CI 1.01-1.32)。
关键数值与推荐
- PIM依据Laroche列表加额外标准(涉及不适当长期用药)定义。
- 多重用药与PIM由法国国家健康保险报销数据评估。
- 衰弱采用Strawbridge问卷每年评估。
- 采用马尔可夫多状态模型分析PIM与衰弱状态变化(发生与恢复)的关系。
临床怎么用
- 对早期老年期多重用药者应关注衰弱风险,尤其使用非甾体抗炎药者。
- 可借助报销数据识别PIM并优化处方,减少多重用药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: High-risk prescribing can have deleterious effects on the health of older people. This study aimed to assess the role of inappropriate prescribing on changes in frailty status over 3 years of follow-up. DESIGN, SETTING: This is a prospective observational study nested in the GAZEL cohort. PARTICIPANTS: The study sample included 12,405 community-dwelling people aged 58 to 73 in 2012, and followed for 3 years. MEASUREMENT: Polypharmacy and potentially inappropriate medications (PIMs) were assessed from reimbursement data by the French National Health Insurance. Frailty was evaluated each year with the Strawbridge questionnaire. PIMs were defined according to the Laroche list plus additional criteria dealing with inappropriate prolonged use of medications. The relationship between PIMs and changes in frailty status (incident frailty and recovery) was analyzed with Markov multistate modeling. RESULTS: The prevalence of frailty increased from 14% in 2012 to 17% in 2014, whereas the frequency of PIMs was 29% in 2012 and 23% in 2014. Polypharmacy (5-9 drugs: aHR 1.31, 95% CI 1.14-1.50; and 10 drugs or more: aHR 1.57, 95% CI 1.28-1.92) and potentially inappropriate use of nonsteroidal anti-inflammatory drugs (aHR 1.33, 95% CI 1.04-1.71) were significantly associated with incident frailty, when the presence of at least 1 PIM presented a small association with the risk of becoming frail (aHR 1.15, 95% CI 1.01-1.32). CONCLUSIONS/IMPLICATIONS: This study brings new elements to our knowledge regarding the association between inappropriate prescribing and frailty in older adults, which support research development to alert on inappropriate prescribing and to improve drug prescribing among old people, especially with polypharmacy.
引用
- Martinot P, Landré B, Zins M, et al. Association Between Potentially Inappropriate Medications and Frailty in the Early Old Age: A Longitudinal Study in the GAZEL Cohort. J Am Med Dir Assoc. 2018. PMID: 30172683. doi:10.1016/j.jamda.2018.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。